Hound Labs

About:

Hound Labs has developed the first cannabis breath test that limits detection to the workday giving employers + employees a fair solution.

Website: http://houndlabs.com

Twitter/X: HoundLabsInc

Top Investors: Benchmark, Icon Ventures, Main Street Advisors, Entourage Effect Capital, Tuatara Capital

Description:

Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective result to support workplace policies that prohibit use immediately before or during the workday, but do not penalize employees for cannabis use away from work. Founded in 2014, Hound Labs is headquartered in Fremont, California. Benchmark, EEC, Icon Ventures, Intrinsic Capital Partners, NFP Ventures, Tuatara Capital, and individual investors have funded the Company. Learn more at HoundLabs.com.

Total Funding Amount:

$130M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oakland, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)houndlabs.com

Founders:

Jenny Lynn, Kuni Oh, Mike Lynn

Number of Employees:

51-100

Last Funding Date:

2021-10-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai